Kaplan–Meier curves for the non-prespecified explorative composite cardiovascular endpoint of sudden cardiac death and fatal and nonfatal acute myocardial infarction or stroke in addition to coronary or peripheral revascularization, or amputation because of critically ischemic limb.

Kaplan–Meier curves show the proportion of patients who reached the exploratory composite cardiovascular endpoint in the benazepril, valsartan, and combination therapy groups during a median follow-up of 66 months. HRs and 95% confidence intervals are crude (unadjusted) and adjusted for center, age, sex, smoking habit, baseline mean BP, and log-transformed UAE. Adj, adjusted; BP, blood pressure; HR, hazard ratio; UAE, urinary albumin excretion; unadj, unadjusted.

(TIF)